{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:56:54Z","timestamp":1791295014515,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1023\/a:1021831621210","type":"journal-article","created":{"date-parts":[[2003,3,21]],"date-time":"2003-03-21T18:56:02Z","timestamp":1048272962000},"page":"95-102","source":"Crossref","is-referenced-by-count":147,"title":["Glycogen Storage Diseases"],"prefix":"10.1007","volume":"4","author":[{"given":"Joseph I.","family":"Wolfsdorf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5109165_CR1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0889-8529(05)70103-1","volume":"28","author":"JI Wolfsdorf","year":"1999","unstructured":"Wolfsdorf JI, Holm IA, Weinstein DA. Glycogen storage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy. Endocrinol Metab Clin North Am 1999;28:801\u2013823.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"5109165_CR2","first-page":"1521","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"YT. Chen","year":"2001","unstructured":"Chen YT. Glycogen storage diseases. In: Scriver C, Beaudet A, Sly W, Valle D, Childs B, Kinzler KW, Vogelstein B, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001;1521\u20131555."},{"key":"5109165_CR3","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/adc.52.7.573","volume":"52","author":"A Aynsley-Green","year":"1977","unstructured":"Aynsley-Green A, Williamson DH, Gitzelmann R. Hepatic glycogen synthetase deficiency. Definition of syndrome from metabolic and enzyme studies on a 9-year-old girl. Arch Dis Child 1977;52:573\u2013 579.","journal-title":"Arch Dis Child"},{"key":"5109165_CR4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1172\/JCI2890","volume":"102","author":"M Orho","year":"1998","unstructured":"Orho M, Bosshard NU, Buist NRM, Gitzelmann R, Aynsley-Green A, Bl\u00fcmel P, Gannon M, Nuttall F, Groop L. Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0. J Clin Invest 1998;102:507\u2013515.","journal-title":"J Clin Invest"},{"key":"5109165_CR5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev.nutr.19.1.379","volume":"19","author":"RC Nordlie","year":"1999","unstructured":"Nordlie RC, Foster JD, Lange AJ. Regulation of glucose production by the liver. Ann Rev Nutr 1999;19:379\u2013406.","journal-title":"Ann Rev Nutr"},{"key":"5109165_CR6","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1074\/jbc.273.11.6144","volume":"273","author":"CJ Pan","year":"1998","unstructured":"Pan CJ, Lei KJ, Annabi B, Hemrika W, Chou JY. Transmembrane topology of glucose-6-phosphatase. J Biol Chem 1998;273:6144\u20136148.","journal-title":"J Biol Chem"},{"key":"5109165_CR7","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1074\/jbc.274.9.5532","volume":"274","author":"H Hiraiwa","year":"1999","unstructured":"Hiraiwa H, Pan CJ, Lin B, Moses SW, Chou JY. Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b. J Biol Chem 1999;274:5532\u20135536.","journal-title":"J Biol Chem"},{"key":"5109165_CR8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1172\/JCI117645","volume":"95","author":"K-J Lei","year":"1995","unstructured":"Lei K-J, Shelly LL, Lin B, Sidbury JB, Chen Y-T, Nordlie RC, Chou JY. Mutations in the glucose-6-phosphatase gene are associated with glycogen storage diseases types 1a and 1aSP but not 1b or 1c. J Clin Invest 1995;95:234\u2013240.","journal-title":"J Clin Invest"},{"key":"5109165_CR9","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1086\/302068","volume":"63","author":"M Veiga-da-Cunha","year":"1998","unstructured":"Veiga-da-Cunha M, Gerin I, Chen YT, de Barsy T, de Lonlay P, Dionisi-Vici C, Fenske CD, Lee PJ, Leonard JV, Maire I, McConkie-Rosell A, Schweitzer S, Vikkula M, Van Schaftingen E. A gene on chromosome 11q23 coding for a putative glucose-6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic. Am J Hum Genet 1998;63:976\u2013983.","journal-title":"Am J Hum Genet"},{"key":"5109165_CR10","first-page":"717","volume":"7","author":"M Veiga-da-Cunha","year":"1999","unstructured":"Veiga-da-Cunha M, Gerin I, Chen YT, Lee PJ, Leonard JV, Maire I, Wendel U, Vikkula M, Van Schaftingen E. The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur JHumGenet 1999;7:717\u2013 723.","journal-title":"Eur JHumGenet"},{"key":"5109165_CR11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1067\/mpd.2000.107472","volume":"137","author":"S Kure","year":"2000","unstructured":"Kure S, Hou DC, Suzuki Y, Yamagishi A, Hiratsuka M, Fukuda T, Sugie H, Kondo N, Matsubara Y, Narisawa K. Glycogen storage disease type Ib without neutropenia. J Pediatr 2000;137:253\u2013 256.","journal-title":"J Pediatr"},{"key":"5109165_CR12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/00006450-200009000-00011","volume":"48","author":"BW Weston","year":"2000","unstructured":"Weston BW, Lin JL, Muenzer J, Cameron HS, Arnold RR, Seydewitz HH, Mayatepek E, Van Schaftingen E, Veiga-da-Cunha M, Matern D, Chen YT. Glucose-6-phosphatase mutation G188R confers an atypical glycogen storage disease type 1b phenotype. Pediatr Res 2000;48:329\u2013334.","journal-title":"Pediatr Res"},{"key":"5109165_CR13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/mpd.2000.105232","volume":"137","author":"G Visser","year":"2000","unstructured":"Visser G, Rake JP, Fernandes J, Labrune P, Leonard JV, Moses S, Ullrich K, Smit GP. Neutropenia, neutrophil dysfunction, and in-flammatory bowel disease in glycogen storage disease type Ib: Results of the European Study on Glycogen Storage Disease Type I. J Pediatr 2000;137:187\u2013191.","journal-title":"J Pediatr"},{"key":"5109165_CR14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood.V97.2.376","volume":"97","author":"S Calderwood","year":"2001","unstructured":"Calderwood S, Kilpatrick L, Douglas SD, Freedman M, Smith-Whitley K, Rolland M, Kurtzberg J. Recombinant human granulocyte colony-stimulating factor therapy for patients with neutropenia and\/or neutrophil dysfunction secondary to glycogen storage disease type 1b. Blood 2001;97:376\u2013382.","journal-title":"Blood"},{"key":"5109165_CR15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1067\/mpd.2001.111322","volume":"138","author":"DA Weinstein","year":"2001","unstructured":"Weinstein DA, Somers MJ, Wolfsdorf JI. Decreased urinary citrate excretion in type 1a glycogen storage disease. J Pediatr 2001;138:378\u2013382.","journal-title":"J Pediatr"},{"key":"5109165_CR16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/BF02679991","volume":"161","author":"DA Weinstein","year":"2002","unstructured":"Weinstein DA, Wolfsdorf JI. Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr 2002;161:535\u2013539.","journal-title":"Eur J Pediatr"},{"key":"5109165_CR17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1023\/A:1005346824368","volume":"20","author":"JI Wolfsdorf","year":"1997","unstructured":"Wolfsdorf JI, Laffel LMB, Crigler JF, Jr. Metabolic control and renal dysfunction in type I glycogen storage disease. J Inher Metab Dis 1997;20:559\u2013568.","journal-title":"J Inher Metab Dis"},{"key":"5109165_CR18","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s004310051281","volume":"159","author":"JP Rake","year":"2000","unstructured":"Rake JP, ten Berge AM, Visser G, Verlind E, Niezen-Koning KE, Buys CH, Smit GP, Scheffer H. Glycogen storage disease type Ia: Recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flowchart. Eur J Pediatr 2000;159:322\u2013330.","journal-title":"Eur J Pediatr"},{"key":"5109165_CR19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2337\/diab.26.11.1016","volume":"26","author":"DM Bier","year":"1977","unstructured":"Bier DM, Leake RD, Haymond MW, Arnold KJ, Gruenke LD, Sperling MA, Kipnis DM. Measurement of \u201ctrue\u201d glucose production rates in infancy and childhood with 6,6-dideuteroglucose. Diabetes 1977;26:1016\u20131023.","journal-title":"Diabetes"},{"key":"5109165_CR20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/geno.1996.0611","volume":"38","author":"Y Bao","year":"1996","unstructured":"Bao Y, Dawson TL, Jr. Chen YT. Human glycogen debranching enzyme gene (AGL): Complete structural organization and characterization of the 5' flanking region. Genomics 1996;38:155\u2013165.","journal-title":"Genomics"},{"key":"5109165_CR21","doi-asserted-by":"crossref","first-page":"9294","DOI":"10.1016\/S0021-9258(19)50422-7","volume":"267","author":"BZ Yang","year":"1992","unstructured":"Yang BZ, Ding JH, Enghild JJ, Bao Y, Chen YT. Molecular cloning and nucleotide sequence ofc DNA encoding human muscle glycogen debranching enzyme. J Biol Chem 1992;267:9294\u20139299.","journal-title":"J Biol Chem"},{"issue":"1\/2","key":"5109165_CR22","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0378-1119(97)00291-6","volume":"197","author":"Y Bao","year":"1997","unstructured":"Bao Y, Yang BZ, Lawson TL, Jr., Chen YT. Isolation and nucleotide sequence of human liver glycogen debranching enzyme mRNA: Identification of multiple tissue-specific isoforms. Gene 1997;197(1\/2):389\u2013398.","journal-title":"Gene"},{"key":"5109165_CR23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/abbi.1993.1505","volume":"306","author":"W Liu","year":"1993","unstructured":"Liu W, de Castro ML, Takrama J, Bilous PT, Vinayagamoorthy T, Madsen NB, Bleackley RC. Molecular cloning, sequencing, and analysis of the cDNA for rabbit muscle glycogen debranching enzyme. Arch Biochem Biophys 1993;306:232\u2013239.","journal-title":"Arch Biochem Biophys"},{"key":"5109165_CR24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1172\/JCI118799","volume":"98","author":"J Shen","year":"1996","unstructured":"Shen J, Bao Y, Liu HM, Lee P, Leonard JV, Chen YT. Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle. J Clin Invest 1996;98:352\u2013357.","journal-title":"J Clin Invest"},{"key":"5109165_CR25","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000484776","volume":"5","author":"R Parvari","year":"1997","unstructured":"Parvari R, Moses S, Shen J, Hershkovitz E, Lerner A, Chen YT. A single-base deletion in the 3\u2032-coding region of glycogendebranching enzyme is prevalent in glycogen storage disease type IIIA in a population of North African Jewish patients. Eur J Hum Genet 1997;5:266\u2013270.","journal-title":"Eur J Hum Genet"},{"key":"5109165_CR26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-116-11-896","volume":"116","author":"RA Coleman","year":"1992","unstructured":"Coleman RA, Winter HS, Wolf B, Gilchrist JM, Chen YT. Glycogen storage disease type III (glycogen debranching enzyme deficiency): Correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med 1992;116:896\u2013900.","journal-title":"Ann Intern Med"},{"key":"5109165_CR27","first-page":"276","volume":"24","author":"P Labrune","year":"1997","unstructured":"Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M. Hepatocellular adenomas in glycogen storage disease type I and III: A series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997;24:276\u2013279.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"suppl2","key":"5109165_CR28","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1007\/PL00014320","volume":"158","author":"D Matern","year":"1999","unstructured":"Matern D, Starzl TE, Arnaoult W, Barnard J, Bynon JS, Dhawan A, Emond J, Haagsma EB, Hug G, Lachaux A, Smit GP, Chen YT. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 1999;158(suppl 2):S43\u2013S48.","journal-title":"Eur J Pediatr"},{"key":"5109165_CR29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/hep.510250307","volume":"25","author":"EB Haagsma","year":"1997","unstructured":"Haagsma EB, Smit GP, Niezen-Koning KE, Gouw AS, Meerman L, Slooff MJ. Type IIIb glycogen storage disease associated with endstage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group. Hepatology 1997;25:537\u2013540.","journal-title":"Hepatology"},{"key":"5109165_CR30","first-page":"57","volume-title":"Protein Dysfunction in Human Genetic Disease","author":"MW. Kiliman","year":"1997","unstructured":"Kiliman MW. Glycogen storage disease due to phosphorylase kinase deficiency. In: Swallow DM, Edwards YH, eds. Protein Dysfunction in Human Genetic Disease. BIOS Scientific: Oxford, 1997;57\u201375."},{"key":"5109165_CR31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/301790","volume":"62","author":"B Burwinkel","year":"1998","unstructured":"Burwinkel B, Bakker HD, Herschkovitz E, Moses SW, Shin YS, Kilimann MW. Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. Am J Hum Genet 1998;62:785\u2013791.","journal-title":"Am J Hum Genet"},{"key":"5109165_CR32","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/hmg\/7.5.865","volume":"7","author":"S Chang","year":"1998","unstructured":"Chang S, Rosenberg MJ, Morton H, Francomano CA, Biesecker LG. Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI. Hum Mol Genet 1998;7:865\u2013870.","journal-title":"Hum Mol Genet"},{"key":"5109165_CR33","first-page":"381","volume":"56","author":"IE van den Berg","year":"1995","unstructured":"van den Berg IE, van Beurden EA, Malingre HE, van Amstel HK, Poll-The BT, Smeitink JA, Lamers WH, Berger R. X-linked liver phosphorylase kinase deficiency is associated with mutations in the human liver phosphorylase kinase alpha subunit. Am J Hum Genet 1995;56:381\u2013387.","journal-title":"Am J Hum Genet"},{"key":"5109165_CR34","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/hmg\/4.1.77","volume":"4","author":"J Hendrickx","year":"1995","unstructured":"Hendrickx J, Coucke P, Dams E, Lee P, Odievre M, Corbeel L, Fernandes JF, Willems PJ. Mutations in the phosphorylase kinase gene PHKA2 are responsible for X-linked liver glycogen storage disease. Hum Mol Genet 1995;4:77\u201383.","journal-title":"Hum Mol Genet"},{"key":"5109165_CR35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s004390050715","volume":"102","author":"B Burwinkel","year":"1998","unstructured":"Burwinkel B, Amat L, Gray RGF, Matsuo N, Muroya K, Narisawa K, Sokol RJ, Vilaseca MA, Kilimann MW. Variability of biochemical and clinical phenotype in X-linked liver glycogenosis with mutations in the phosphorylase kinase PHKA2 gene. Hum Genet 1998;102:423\u2013429.","journal-title":"Hum Genet"},{"key":"5109165_CR36","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/hmg\/5.5.649","volume":"5","author":"J Hendrickx","year":"1996","unstructured":"Hendrickx J, Dams E, Coucke P, Lee P, Fernandes J, Willems PJ. X-linked liver glycogenosis type II (XLG II) is caused by mutations in PHKA2, the gene encoding the liver a subunit of phosphorylase kinase. Hum Mol Genet 1996;5:649\u2013652.","journal-title":"Hum Mol Genet"},{"key":"5109165_CR37","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/hmg\/5.5.653","volume":"5","author":"B Burwinkel","year":"1996","unstructured":"Burwinkel B, Shin YS, Bakker HD, Deutsch J, Lozano MJ, Maire I, Kilimann MW. Mutation hotspots in the PHKA2 gene in X-linked liver glycogenosis due to phosphorylase kinase deficiency with atypical activity in blood cells (XLG2). Hum Mol Genet 1996;5:653\u2013 658.","journal-title":"Hum Mol Genet"},{"key":"5109165_CR38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/BF02106291","volume":"149","author":"PJ Willems","year":"1990","unstructured":"Willems PJ, Gerver WJ, Berger R, Fernandes J. The natural history of liver glycogenosis due to phosphorylase kinase deficiency: A longitudinal study of 41 patients. Eur J Pediatr 1990;149:268\u2013271.","journal-title":"Eur J Pediatr"},{"key":"5109165_CR39","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1515\/JPEM.1999.12.3.363","volume":"12","author":"ON Elpeleg","year":"1999","unstructured":"Elpeleg ON The molecular background of glycogen metabolism disorders. J Pediatr Endocrinol Metab 1999;12:363\u2013379.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"5109165_CR40","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF02190663","volume":"153","author":"A Nakai","year":"1994","unstructured":"Nakai A, Shigematsu Y, Takano T, Kikawa Y, Sudo M. Uncooked cornstarch treatment for hepatic phosphorylase kinase deficiency. Eur J Pediatr 1994;153:581\u2013583.","journal-title":"Eur J Pediatr"},{"key":"5109165_CR41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1043-2760(98)00123-4","volume":"10","author":"JY Chou","year":"1999","unstructured":"Chou JY, Mansfield BC. Molecular Genetics of Type I Glycogen Storage Diseases. Trends Endocrinol Metab 1999;10:104\u2013113.","journal-title":"Trends Endocrinol Metab"}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1021831621210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1021831621210\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1021831621210.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T09:31:35Z","timestamp":1754472695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1021831621210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["5109165"],"URL":"https:\/\/doi.org\/10.1023\/a:1021831621210","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}